FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

49616005: Monoclonal antibody (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
82640015 Monoclonal antibody en Synonym Active Entire term case insensitive SNOMED CT core module
787314018 Monoclonal antibody (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3779819014 Monoclonal protein en Synonym Active Entire term case insensitive SNOMED CT core module
3779820015 Monoclonal immunoglobulin en Synonym Active Entire term case insensitive SNOMED CT core module

150 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Monoclonal antibody Is a Non-organ specific antibody false Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Antibody true Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Monoclonal immunoglobulin false Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Drug or medicament true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Muromonab-CD3 5mg/5mL injection - product Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Abciximab 10mg/5mL injection - product Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Basiliximab 20mg injection (pdr for recon)+solvent - product Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Daclizumab 25mg/5mL infusion concentrate - product Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Infliximab 100mg infusion concentrate (pdr for recon) - product Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Etanercept 25mg injection (pdr for recon)+solvent - product Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Trastuzumab 150mg infusion concentrate (pdr for recon) - product Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
MabCampath 30mg/3mL infusion concentrate Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Basiliximab 10mg injection (pdr for recon)+solvent Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Orthoclone OKT3 5mg/5mL injection Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
ReoPro 10mg/5mL injection Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Simulect 20mg injection (pdr for recon)+solvent Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Zenapax 25mg/5mL infusion concentrate Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Remicade 100mg infusion concentrate (pdr for recon) Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Enbrel 25mg injection (pdr for recon)+solvent Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Herceptin 150mg infusion concentrate (pdr for recon) Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Simulect 10mg injection (pdr for recon)+solvent Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Risankizumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Tixagevimab Is a True Monoclonal antibody Inferred relationship Existential restriction modifier
Cilgavimab Is a True Monoclonal antibody Inferred relationship Existential restriction modifier
Fremanezumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Amivantamab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Benralizumab 30mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Sotorasib Is a True Monoclonal antibody Inferred relationship Existential restriction modifier
Teclistamab Is a True Monoclonal antibody Inferred relationship Existential restriction modifier
Faricimab Is a True Monoclonal antibody Inferred relationship Existential restriction modifier
Alirocumab 300mg/2ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Romosozumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Tezepelumab Is a True Monoclonal antibody Inferred relationship Existential restriction modifier
cemiplimab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Dupilumab 200mg/1.14ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Mepolizumab 100mg/1ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Mepolizumab 100mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Casirivimab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Imdevimab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Dupilumab 300mg/2ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Dupilumab 200mg/1.14ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Polatuzumab vedotin Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Eptinezumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Bimekizumab Is a True Monoclonal antibody Inferred relationship Existential restriction modifier
Tralokinumab Is a True Monoclonal antibody Inferred relationship Existential restriction modifier
Risankizumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Daratumumab 1.8g/15ml solution for injection vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Isatuximab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Emapalumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Mogamulizumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Ravulizumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Bamlanivimab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Ustekinumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Stelara 45mg/0.5ml solution for injection vials (Janssen-Cilag Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Tocilizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Tocilizumab 200mg/10ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Tocilizumab 400mg/20ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Tocilizumab 80mg/4ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
RoActemra 200mg/10ml concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
RoActemra 80mg/4ml concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
RoActemra 400mg/20ml concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Canakinumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Ofatumumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ofatumumab 100mg/5ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Arzerra 100mg/5ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Stelara 45mg/0.5ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Ipilimumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ipilimumab 200mg/40ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ipilimumab 50mg/10ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Yervoy 50mg/10ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Yervoy 200mg/40ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Belimumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Belimumab 120mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Belimumab 400mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Benlysta 400mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Benlysta 120mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Catumaxomab Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Catumaxomab 10micrograms/0.1ml solution for infusion pre-filled syringes Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Catumaxomab 50micrograms/0.5ml solution for infusion pre-filled syringes Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Removab 10micrograms/0.1ml concentrate for solution for infusion pre-filled syringes (Fresenius Biotech) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Removab 50micrograms/0.5ml concentrate for solution for infusion pre-filled syringes (Fresenius Biotech) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Brentuximab vedotin Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Brentuximab vedotin 50mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Adcetris 50mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Brentuximab vedotin Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Pertuzumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Pertuzumab 420mg/14ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Perjeta 420mg/14ml concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Trastuzumab emtansine Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Trastuzumab emtansine 100mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Vedolizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Vedolizumab 300mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Entyvio 300mg powder for concentrate for solution for infusion vials (Takeda UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Siltuximab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Siltuximab 100mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Siltuximab 400mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Sylvant 400mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Sylvant 100mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier

Start Previous Page 3 of 5 Next End

This concept is not in any reference sets

Back to Start